Related by context. Frequent words. (Click for all words.) 63 multicenter clinical 62 Cardiovascular Risk 62 randomized controlled clinical 62 SWOG 61 Metabolomics 60 placebo controlled clinical 60 Phase Ib clinical 60 Cervical Cancer Screening 59 prospective observational 59 Multicenter 59 randomized clinical 59 multicentre 58 retrospective cohort study 58 randomized Phase III 58 CAPRISA 58 SPIRIT III 58 NSABP 58 multicenter study 58 placebo controlled randomized 58 Phase III Clinical Trial 58 Acute Myocardial Infarction 57 Glioma 57 pharmacodynamic effects 57 Radiation Therapy Oncology 57 Thrombolysis 57 Phase III randomized 57 substudy 57 ALLHAT 56 Gynecologic Oncology Group 56 blind randomized controlled 56 Bladder Cancer 56 blinded placebo controlled 56 Hepatitis C Virus 56 pertuzumab 56 Rosuvastatin 56 Atherosclerosis Risk 56 liver transplant recipients 56 Breast Cancer Risk 56 tesmilifene 56 Azedra 56 Colorectal Cancer Screening 56 prospective cohort 56 prospective randomized controlled 56 Health Initiative WHI 56 SABCS 55 Adjuvant 55 Postmenopausal Women 55 Randomized Controlled Trial 55 multicenter randomized 55 phase IIa 55 Phase 1b trial 55 Breast Cancer Screening 55 Myocardial Infarction 55 Pivotal Trial 55 ataluren 55 Apixaban 55 double blinded placebo 55 Coronary Heart Disease 55 Vascular Disease 55 TRITON TIMI 55 Ischemic 55 EORTC 55 Estradiol 55 Eye Disease 54 postmenopausal women 54 Insulin Resistance 54 SYNTAX 54 candesartan 54 Prostate Cancer Treatment 54 randomized controlled clinical trials 54 Colorectal 54 Meta Analysis 54 AREDS 54 Heart Failure Patients 54 Clinical Trial Results 54 Diabetic Retinopathy 54 dutasteride 54 Cancer Vaccine 54 multicenter 54 Pivotal Phase 54 RTOG 54 Chronic Lymphocytic Leukemia 54 subgroup analyzes 54 Metastatic Melanoma 54 PRECiSE 54 Professionals Follow 54 Lp PLA2 54 phase IIb 53 immunohistochemical 53 Phase III Trial 53 Advanced Prostate Cancer 53 elotuzumab 53 elevated CRP 53 Solid Tumors 53 Stroke Prevention 53 Pivotal Phase III 53 NHANES 53 Phase Ia 53 multicenter randomized double 53 Phase Ib 53 tipranavir